164 related articles for article (PubMed ID: 10514442)
1. Hereditary pancreatitis-associated mutation asn(21) --> ile stabilizes rat trypsinogen in vitro.
Sahin-Tóth M
J Biol Chem; 1999 Oct; 274(42):29699-704. PubMed ID: 10514442
[TBL] [Abstract][Full Text] [Related]
2. Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis.
Sahin-Tóth M
J Biol Chem; 2000 Jul; 275(30):22750-5. PubMed ID: 10801865
[TBL] [Abstract][Full Text] [Related]
3. [Significance of trypsinogen gene mutations in the etiology of hereditary pancreatitis].
Sahin-Tóth M; Tóth M
Orv Hetil; 2001 Mar; 142(12):603-6. PubMed ID: 11324217
[TBL] [Abstract][Full Text] [Related]
4. Trypsinogen stabilization by mutation Arg117-->His: a unifying pathomechanism for hereditary pancreatitis?
Sahin-Tóth M; Gráf L; Tóth M
Biochem Biophys Res Commun; 1999 Oct; 264(2):505-8. PubMed ID: 10529393
[TBL] [Abstract][Full Text] [Related]
5. High-affinity Ca(2+) binding inhibits autoactivation of rat trypsinogen.
Sahin-Tóth M; Tóth M
Biochem Biophys Res Commun; 2000 Aug; 275(2):668-71. PubMed ID: 10964720
[TBL] [Abstract][Full Text] [Related]
6. Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen.
Sahin-Tóth M; Tóth M
Biochem Biophys Res Commun; 2000 Nov; 278(2):286-9. PubMed ID: 11097832
[TBL] [Abstract][Full Text] [Related]
7. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen.
Sahin-Tóth M
Pancreatology; 2001; 1(5):461-5. PubMed ID: 12120225
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.
Szilágyi L; Kénesi E; Katona G; Kaslik G; Juhász G; Gráf L
J Biol Chem; 2001 Jul; 276(27):24574-80. PubMed ID: 11312265
[TBL] [Abstract][Full Text] [Related]
9. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
10. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
11. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
[TBL] [Abstract][Full Text] [Related]
12. Human cationic trypsinogen. Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation.
Kukor Z; Tóth M; Pál G; Sahin-Tóth M
J Biol Chem; 2002 Feb; 277(8):6111-7. PubMed ID: 11748242
[TBL] [Abstract][Full Text] [Related]
13. Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.
Németh BC; Wartmann T; Halangk W; Sahin-Tóth M
J Biol Chem; 2013 Aug; 288(33):24049-62. PubMed ID: 23814066
[TBL] [Abstract][Full Text] [Related]
14. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
Kukor Z; Tóth M; Sahin-Tóth M
Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
[TBL] [Abstract][Full Text] [Related]
15. The tetra-aspartate motif in the activation peptide of human cationic trypsinogen is essential for autoactivation control but not for enteropeptidase recognition.
Nemoda Z; Sahin-Tóth M
J Biol Chem; 2005 Aug; 280(33):29645-52. PubMed ID: 15970597
[TBL] [Abstract][Full Text] [Related]
16. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology and evolutionary and physiological implications of pancreatitis-associated cationic trypsinogen mutations.
Chen JM; Montier T; Férec C
Hum Genet; 2001 Sep; 109(3):245-52. PubMed ID: 11702203
[TBL] [Abstract][Full Text] [Related]
18. Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.
Pasternak A; Liu X; Lin TY; Hedstrom L
Biochemistry; 1998 Nov; 37(46):16201-10. PubMed ID: 9819212
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the cationic trypsinogen in hereditary pancreatitis.
Teich N; Mössner J; Keim V
Hum Mutat; 1998; 12(1):39-43. PubMed ID: 9633818
[TBL] [Abstract][Full Text] [Related]
20. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
Geisz A; Hegyi P; Sahin-Tóth M
FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
